Cas No.: | 2207569-08-0 |
Chemical Name: | 3-(4-(5-(4-((3-Benzyl-9-methyl-4H,6H-thieno[2,3-e][1,2,4]-triazolo[3,4-c][1,4]oxazepin-2-yl)ethynyl)-1H-pyrazol-1-yl)pent-1-yn-1-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione |
Synonyms: | QCA 570;QCA-570 |
SMILES: | N1C(=O)CCC(N2CC3=C(C2=O)C=CC=C3C#CCCCN2C=C(C#CC3SC4=C(C=3CC3=CC=CC=C3)COCC3=NN=C(C)N34)C=N2)C1=O |
Formula: | C39H33N7O4S |
M.Wt: | 695.798 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | QCA570 is a novel, highly potent efficacious BET degrader (PROTAC); effectively induces degradation of BET proteins and inhibits cell growth in human acute leukemia cell lines at pM level; inhibits cell growth in MV4;11, MOLM-13, and RS4;11 cell lines with IC50 values of 8.3, 62, and 32 pM, respectively; causes complete and durable tumor regression in leukemia xenograft models in mice. |